Longitudinal Association Between Hemoglobin A1c and Erythropoietin Responsiveness in Patients With Diabetes Receiving Maintenance Hemodialysis

Introduction HbA1c may underestimate glycemic exposure in patients receiving maintenance hemodialysis because erythrocyte turnover is affected by renal anemia and erythropoiesis-stimulating agent (ESA) therapy. We examined whether longitudinal changes in ESA responsiveness were associated with HbA1c independently of measured blood glucose. Methods This retrospective longitudinal study included 38 patients with diabetes receiving maintenance hemodialysis, contributing 1,149 repeated observations. Three-observation rolling means of blood glucose and the erythropoietin resistance index (ERI) were decomposed into within-patient and between-patient components. Linear mixed-effects models with patient-specific random intercepts evaluated associations with HbA1c. Results Within-patient increases in three-observation rolling mean blood glucose were positively associated with HbA1c (β = 0.0102, 95% CI 0.0093 to 0.0111, P < 0.001). In contrast, within-patient increases in ERI were associated with lower HbA1c after adjustment for measured blood glucose and other covariates (β = −0.0284, 95% CI − 0.0348 to − 0.0220, P < 0.001), whereas the between-patient ERI component was not significant (β = 0.0047, 95% CI − 0.0276 to 0.0370, P = 0.776). The within-patient association remained consistent across multiple sensitivity analyses. Conclusion In patients with diabetes receiving maintenance hemodialysis, within-patient increases in ERI were associated with lower HbA1c after adjustment for routinely measured blood glucose, whereas between-patient differences in ERI were not. Temporal variation in ESA responsiveness may provide additional context when interpreting serial HbA1c values. Because continuous glucose monitoring was not performed, independence from actual glycemic exposure could not be established.

Authors

Publication Details

Journal
Research Square
Published
2026-11-19
DOI
https://doi.org/10.21203/rs.3.rs-11575563/v1
Primary Topic
Erythropoietin and Anemia Treatment
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Longitudinal Association Between Hemoglobin A1c and Erythropoietin Responsiveness in Patients With Diabetes Receiving Maintenance Hemodialysis

Yukinobu Ikegishi
Research Square
Erythropoietin and Anemia Treatment
preprint

Longitudinal Association Between Hemoglobin A1c and Erythropoietin Responsiveness in Patients With Diabetes Receiving Maintenance Hemodialysis

Yukinobu Ikegishi
preprint en

Abstract

Introduction HbA1c may underestimate glycemic exposure in patients receiving maintenance hemodialysis because erythrocyte turnover is affected by renal anemia and erythropoiesis-stimulating agent (ESA) therapy. We examined whether longitudinal changes in ESA responsiveness were associated with HbA1c independently of measured blood glucose. Methods This retrospective longitudinal study included 38 patients with diabetes receiving maintenance hemodialysis, contributing 1,149 repeated observations. Three-observation rolling means of blood glucose and the erythropoietin resistance index (ERI) were decomposed into within-patient and between-patient components. Linear mixed-effects models with patient-specific random intercepts evaluated associations with HbA1c. Results Within-patient increases in three-observation rolling mean blood glucose were positively associated with HbA1c (β = 0.0102, 95% CI 0.0093 to 0.0111, P < 0.001). In contrast, within-patient increases in ERI were associated with lower HbA1c after adjustment for measured blood glucose and other covariates (β = −0.0284, 95% CI − 0.0348 to − 0.0220, P < 0.001), whereas the between-patient ERI component was not significant (β = 0.0047, 95% CI − 0.0276 to 0.0370, P = 0.776). The within-patient association remained consistent across multiple sensitivity analyses. Conclusion In patients with diabetes receiving maintenance hemodialysis, within-patient increases in ERI were associated with lower HbA1c after adjustment for routinely measured blood glucose, whereas between-patient differences in ERI were not. Temporal variation in ESA responsiveness may provide additional context when interpreting serial HbA1c values. Because continuous glucose monitoring was not performed, independence from actual glycemic exposure could not be established.

Research Square
Erythropoietin and Anemia Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon